Plus   Neg

Stock Alert: PGT Innovations Jumps 21% As Q1 Results Beat Estimates

Shares of are PGT Innovations, Inc. (PGTI), a manufacturer of impact-resistant residential windows and doors, are gaining more than 21 percent or $2.10 in Wednesday's morning trade at $11.87 after the company's financial results for the first quarter beat analysts' estimates. The stock has traded in a range of $6.88 to $18.48 in the past 52 weeks.

Wednesday, PGT Innovations said its first-quarter net income surged to $15.60 million or $0.26 per share from $8.26 million or $0.14 per share in the year-ago period. Adjusted earnings were $0.28 per share, compared to $0.16 per share in the prior-year period.

Net sales grew 27 percent to $220.20 million from $173.74 million in the same period last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.13 per share for the quarter on revenues of $191.92 million. Analysts' estimates typically exclude special items.

PGT Innovations has withdrawn its 2020 annual guidance, but projects its second-quarter consolidated net sales, inclusive of NewSouth, to decline in the range of 7 to 10 percent as compared to the prior year.

PGT Innovations noted that it quickly adjusted its operations to meet the changes in demand amid the coronavirus pandemic. However, after seeing a building pipeline of orders in its Florida markets in May, it is starting to build back its capacity to meet the recovering demand.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
H-E-B has issued an all-store recall for Blue Cheese Salmon Burgers citing the presence of an undeclared allergen, the U.S. Food and Drug Administration announced. The products contain wheat, a known allergen, which is not declared on the product label. Consumers with allergy or severe sensitivity to wheat may get serious or life-threatening allergic reaction if they consume these products. The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co.'s (KODK) announcement of a $765 million government loan to make ingredients for Covid-19 drugs, the Wall Street Journal reported citing people familiar with the matter. The National Retail Federation or NRF said that conflicting economic data amid a resurgence in coronavirus cases has made it difficult to predict how steadily the U.S. economic recovery will continue. NRF Chief Economist Jack Kleinhenz noted that based on quarterly and monthly data, the U.S. economic recovery is continuing despite the elevated COVID-19 cases.
Follow RTT